| Literature DB >> 33457120 |
Carlos A Regino1, Vanessa López-Montoya2, Fernado López-Urbano3, Jose C Alvarez1, Alejandro Roman-Gonzalez4.
Abstract
Hypoglycemia is a common medical emergency in the context of insulin treatment in diabetic patients and oral hypoglycemic agents such as sulfonylureas. In anecdotal cases, hypoglycemia is associated with non-islet cell tumor-induced hypoglycemia (NICTH). In hepatocellular carcinoma (HCC), it has been reported in 4-27% of patients, and it is associated with poor prognosis. We present a case report of a patient with hypoglycemia associated with HCC secondary to chronic hepatitis B virus infection without response to treatment with glucagon, steroids, octreotide, and embolizations, who required parenteral nutrition at home. Even though hypoglycemia associated with HCC is a recognized entity, there is not sufficient evidence in its treatment and prevention. The article aims to review the literature on prevention and therapeutic options.Entities:
Keywords: hepatitis b; hepatocellular carcinoma; hypoglycemia; somatostatin; therapeutic chemoembolization
Year: 2020 PMID: 33457120 PMCID: PMC7797408 DOI: 10.7759/cureus.12013
Source DB: PubMed Journal: Cureus ISSN: 2168-8184